Advertisement
Advertisement

AMRN

AMRN logo

Amarin Corp Plc

14.38
USD
Sponsored
-0.12
-0.79%
Jun 01, 10:03 UTC -4
Open

AMRN Earnings Reports

Positive Surprise Ratio

AMRN beat 27 of 42 last estimates.

64%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$45.31M
/
-$0.16
Implied change from Q1 26 (Revenue/ EPS)
+0.40%
/
+77.78%
Implied change from Q2 25 (Revenue/ EPS)
-37.71%
/
-124.24%

Amarin Corp Plc earnings per share and revenue

On Apr 29, 2026, AMRN reported earnings of -0.09 USD per share (EPS) for Q1 26, missing the estimate of 0.08 USD, resulting in a -203.81% surprise. Revenue reached 45.13 million, compared to an expected 44.65 million, with a 1.09% difference. The market reacted with a +2.36% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.16 USD, with revenue projected to reach 45.31 million USD, implying an increase of 77.78% EPS, and increase of 0.40% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Compugen Ltd
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.08
Surprise
-8.11%
logo
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
logo
Scilex Holding Company Common Stock
Report Date
May 20, 2026 For Q1 26
Estimate
-
Actual
-$4.76
Surprise
-
logo
OS Therapies Incorporated
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.27
Surprise
-49.83%
logo
Roivant Sciences Ltd. Common Shares
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.35
Actual
-$0.57
Surprise
-64.63%
logo
Belite Bio, Inc - ADR
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.64
Actual
-$0.68
Surprise
-4.87%
logo
Immunovant, Inc. Common Stock
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.61
Actual
-$0.73
Surprise
-19.11%
logo
Akari Therapeutics plc ADR (0.01 USD)
Report Date
May 19, 2026 For Q1 26
Estimate
-$1.40
Actual
-$1.57
Surprise
-11.81%
logo
EVOGENE LTD.
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.60
Surprise
-117.86%
FAQ
For Q1 2026, Amarin Corp Plc reported EPS of -$0.09, missing estimates by -203.81%, and revenue of $45.13M, 1.09% above expectations.
The stock price moved up 2.36%, changed from $13.96 before the earnings release to $14.29 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 3 analysts, Amarin Corp Plc is expected to report EPS of -$0.16 and revenue of $45.31M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement